Tag: 4-Chlorokynurenine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to 4-Chlorokynurenine

Vistagen Therapeutics Inc to Post Q2 2020 Earnings of ($0.15) Per Share, William Blair Forecasts ...

Added to Collection on: 2019-09-24 06:52:30

Tags for this article:

Financial ratios
Finance
Money
Economy
Antidepressants
Fundamental analysis
NMDA receptor antagonists
4-Chlorokynurenine
Prodrugs
Price?earnings ratio
Earnings per share
Securities research
VistaGen Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Vistagen Therapeutics (NASDAQ:VTGN) Rating Reiterated by Chardan Capital

Added to Collection on: 2019-12-04 12:18:45

Tags for this article:

Finance
Money
Drugs
Antidepressants
NMDA receptor antagonists
Alternative investment management companies
Stock market
4-Chlorokynurenine
Prodrugs
Price?earnings ratio
Hedge fund
Stock
VistaGen Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Short Interest in Vistagen Therapeutics Inc (NASDAQ:VTGN) Increases By 15.2%

Added to Collection on: 2020-02-04 09:30:00

Tags for this article:

Finance
Financial markets
Money
Antidepressants
NMDA receptor antagonists
4-Chlorokynurenine
Chloroarenes
Prodrugs
Stock
Short
Price?earnings ratio
NASDAQ
VistaGen Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for ...

Added to Collection on: 2020-08-05 21:30:00

Tags for this article:

Chemical compounds
Drugs
Medicine
Hypertension
Chloroarenes
Piperazines
Pulmonary hypertension
Imatinib
Sofinnova
PAH
4-Chlorokynurenine
Pirfenidone
Aerovate Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update ...

Added to Collection on: 2021-02-11 21:22:30

Tags for this article:

Drugs
Health sciences
Antidepressants
PH10
Psychiatry
4-Chlorokynurenine
4-Androstadienol
Balance sheet
Retained earnings
Deferral
Anxiety disorder
Pherine
VistaGen Company
VISTAGEN THERAPEUTICS , INC

Click the tags to see associated articles and topics

View Article Details